Navigation Links
TechPrecision Corporation Receives New $450,000 Medical Purchase Order
Date:2/14/2011

WESTMINSTER, Mass., Feb. 14, 2011 /PRNewswire/ -- TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision metal machining fabrications and assemblies with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today announced that it has received a new medical purchase order valued at approximately $450,000.  The order, from an existing customer, is to machine and fabricate key components and is expected to ship by the end of Q3 quarter of 2011.

"This order continues our diversification strategy and allows us to more fully participate in the medical space," commented James Molinaro, CEO of TechPrecision Corporation. "Our capability to manufacture high value-add components demonstrates our strategy to assist companies with complex prototyping and manufacturing and assembly/test support as they deliver products for the marketplace."

About TechPrecision CorporationTechPrecision Corporation, through its wholly owned subsidiaries, Ranor, Inc., and Wuxi Critical Mechanical Components Co., Ltd., globally manufactures large-scale, metal fabricated and machined precision components and equipment. These products are used in a variety of markets including: alternative energy (Solar and Wind), medical, nuclear, defense, industrial, and aerospace to name a few. TechPrecision's goal is to be an end-to-end global service provider to its customers by furnishing customized and integrated "turn-key" solutions for completed products requiring custom fabrication and machining, assembly, inspection and testing. To learn more about the Company, please visit the corporate website at http://www.techprecision.com. Information on the Company's website or any other website does not constitute a part of this press release.

Safe Harbor StatementThis release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the Company's ability to generate business from long-term contracts rather than individual purchase orders, its dependence upon a limited number of customers, its ability to successfully bid on projects, and other risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.Company Contact:Investor Relations Contact:Mr. Richard F. Fitzgerald

Hayden IRChief Financial Officer

Brett MaasTechPrecision Corporation

Phone: 646-536-7331 Tel: 1-610-246-2116

Email: brett@haydenir.com Email: Fitzgeraldr@techprecision.comwww.techprecision.com
'/>"/>

SOURCE TechPrecision Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
2. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010
3. Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results
4. Unilife Corporation to Announce Financial Results for Fiscal 2011 Second Quarter on Monday, February 14, 2011
5. China Medicine Corporation Receives Manufacturing License for rADTZ
6. Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
7. Sigma-Aldrich Corporation Announces Q4 2010 Conference Call
8. MedCath Corporation to Release First Quarter Results
9. AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the NIH to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedys Disease)
10. Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
11. Celsion Corporation Announces Completion of $5.1 Million Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016   HighPoint Solutions today ... (NRG),s pharmacovigilance technology services division.  NRG is a ... an Oracle Argus Specialized partner, providing drug safety ... companies. --> --> ... sciences capabilities and provides a global scale and ...
(Date:2/8/2016)... BOSTON , Feb. 8, 2016   Intarcia ... John Yee , MD, MPH, into the newly created ... Safety and Operations. Dr. Yee has two decades of ... companies, and at a major academic medical center. Most ... Affairs, US Diabetes, and VP, US Head Medical Officer ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016 Lonza, a ... Sciences Inc., a biopharmaceutical company designing and developing novel ... agreements for the clinical supply of Kodiak,s therapeutic candidates. ... sites, including Slough (UK), Visp (CH) and Nansha (CN). ... Retinal diseases, such as age-related macular degeneration (AMD), cause ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... 09, 2016 , ... Sir Grout, the leading hard surface ... announce that many of their franchises have received the Super Service Award from ... franchises received customer recognition through positive reviews and testimonials, as well as evaluations ...
(Date:2/8/2016)... ... February 08, 2016 , ... CURE Media Group , the nation’s leading ... Multiple Myeloma Heroes Awards event , which will annually honor individuals making heroic contributions ... MM. The MM Heroes Awards nomination process is officially open through February ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... LA, celebrates the beginning of a new charity campaign. As part of their ... Special Advocates (CASA). In the belief that children deserve a voice, and in ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that your clothes ... not alone. According to the Center for Disease Control and Prevention (CDC), 34.9% of ... and certain types of cancer, some of the leading causes of preventable death. ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance ... greater Venice, FL area, has initiated a fundraiser for a two year old ... four days after Christmas. To support this beautiful child who is facing life’s ...
Breaking Medicine News(10 mins):